<DOC>
	<DOCNO>NCT00657839</DOCNO>
	<brief_summary>Assessment efficacy vardenafil treatment subject symptomatic Benign Prostatic Hyperplasia.The purpose study find whether vardenafil improve low urinary tract symptom benign prostatic hyperplasia 8 week daily administration 10 mg BID .</brief_summary>
	<brief_title>Assessment Efficacy Vardenafil Treatment Subjects With Symptomatic Benign Prostatic Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Males 45 64 year age Lower urinary tract symptom &gt; 6 month International Prostate Symptom Score &gt; 12 Prostate Specific Antigen &gt; 3 ng/ml Residual urine volume &gt; 150 History myocardial infarction , stroke lifethreatening arrhythmia within prior 6 month Nitrate use Other exclusion criterion apply acc . Summary Product Characteristics</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Benign Prostate Hyperplasia</keyword>
	<keyword>Vardenafil</keyword>
	<keyword>Genital Disease</keyword>
	<keyword>Male : Signs symptom Benign Prostate Hyperplasia</keyword>
</DOC>